Regeneron Pharmaceuticals Inc.

NAS: REGN

Set Alerts

Market Index

Overview Profile Charts Financials Historical Quotes Analyst Estimates Options SEC Filings Insiders

/marketstate/country/us

Regeneron Pharmaceuticals Inc.

After Hours

--Quotes are delayed by 20 min

May 26, 2023, 6:21 p.m.

REGN

/zigman2/quotes/203149337/composite

724.95

Change

-0.10 -0.01%

Volume

Volume 44,576

Quotes are delayed by 20 min

/zigman2/quotes/203149337/composite

Previous close

$ 725.00

$ 725.05

Change

+0.05 +0.0069%

Day low

Day high

$719.00

$726.77

52 week low

52 week high

$538.01

$837.55

Income Statement Balance Sheet Cash Flow Statement

Annual Financials for Regeneron Pharmaceuticals Inc.

View Ratios

Fiscal year is January-December. All values USD millions.	2018	2019	2020	2021	2022	5-year trend
Sales/Revenue	6.71B	6.56B	8.5B	16.07B	12.17B
Sales Growth	-	-2.28%	29.58%	89.14%	-24.26%
Cost of Goods Sold (COGS) incl. D&A	582.3M	975.4M	1.36B	2.72B	1.9B
COGS excluding D&A	434.1M	765.1M	1.12B	2.44B	1.56B
Depreciation & Amortization Expense	148.2M	210.3M	235.9M	286.2M	341.4M
Depreciation	148.2M	210.3M	235.9M	286.2M	303.8M
Amortization of Intangibles	-	-	-	-	37.6M
COGS Growth	-	67.51%	39.00%	100.89%	-30.18%
Gross Income	6.13B	5.58B	7.14B	13.35B	10.27B
Gross Income Growth	-	-8.91%	27.93%	86.91%	-23.05%
Gross Profit Margin	-	-	-	-	84.38%	NA

	2018	2019	2020	2021	2022	5-year trend
SG&A Expense	3.59B	3.58B	3.85B	4.45B	5.17B
Research & Development	2.04B	2.24B	2.5B	2.62B	3.06B
Other SG&A	1.56B	1.34B	1.35B	1.82B	2.12B
SGA Growth	-	-0.35%	7.36%	15.65%	16.31%
Other Operating Expense	-	(209.2M)	(280.4M)	(45.6M)	(89.9M)
Unusual Expense	41.9M	(118.3M)	(196M)	(386.1M)	489.9M
EBIT after Unusual Expense	2.49B	118.3M	3.77B	9.33B	4.7B
Non Operating Income/Expense	89.2M	131.2M	94.7M	50.2M	59M
Non-Operating Interest Income	-	-	-	-	160.1M
Equity in Affiliates (Pretax)	-	-	-	-	-
Interest Expense	28.2M	30.2M	56.9M	57.3M	59.4M
Interest Expense Growth	-	7.09%	88.41%	0.70%	3.66%
Gross Interest Expense	28.2M	30.2M	56.9M	57.3M	59.4M
Interest Capitalized	-	-	-	-	-
Pretax Income	2.55B	2.43B	3.81B	9.33B	4.86B
Pretax Income Growth	-	-4.87%	56.86%	144.75%	-47.90%
Pretax Margin	-	-	-	-	39.91%	NA
Income Tax	109.1M	313.3M	297.2M	1.25B	520.4M
Income Tax - Current Domestic	228.5M	446.5M	200.2M	1.44B	975.9M
Income Tax - Current Foreign	20.6M	(2.6M)	21.4M	(38.4M)	290.9M
Income Tax - Deferred Domestic	685.7M	(133.7M)	107M	(423.8M)	(800.4M)
Income Tax - Deferred Foreign	(825.7M)	3.1M	(31.4M)	276.7M	54M
Income Tax Credits	-	-	-	-	-
Equity in Affiliates	-	-	-	-	-
Other After Tax Income (Expense)	-	-	-	-	-
Consolidated Net Income	2.44B	2.12B	3.51B	8.08B	4.34B
Minority Interest Expense	-	-	-	-	-
Net Income	2.44B	2.12B	3.51B	8.08B	4.34B
Net Income Growth	-	-13.44%	66.05%	129.86%	-46.28%
Net Margin Growth	-	-	-	-	35.64%	NA
Extraordinaries & Discontinued Operations	-	-	-	-	-
Extra Items & Gain/Loss Sale Of Assets	-	-	-	-	-
Cumulative Effect - Accounting Chg	-	-	-	-	-
Discontinued Operations	-	-	-	-	-
Net Income After Extraordinaries	2.44B	2.12B	3.51B	8.08B	4.34B
Preferred Dividends	-	-	-	-	-
Net Income Available to Common	2.44B	2.12B	3.51B	8.08B	4.34B
EPS (Basic)	22.65	19.38	32.65	76.40	40.51
EPS (Basic) Growth	-	-14.46%	68.51%	133.99%	-46.98%
Basic Shares Outstanding	107.9M	109.2M	107.6M	105.7M	107.1M
EPS (Diluted)	21.29	18.46	30.52	71.97	38.22
EPS (Diluted) Growth	-	-13.28%	65.32%	135.80%	-46.89%
Diluted Shares Outstanding	114.8M	114.6M	115.1M	112.2M	113.5M
EBITDA	2.68B	2.42B	3.81B	9.23B	5.53B
EBITDA Growth	-	-9.79%	57.53%	142.18%	-40.10%
EBITDA Margin	-	-	-	-	45.43%	NA

MarketWatch.com

Follow MarketWatch
RSS
Podcasts

Intraday Data provided by FACTSET and subject to terms of use. Historical and current end-of-day data provided by FACTSET. All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements.

Regeneron Pharmaceuticals Inc.

Annual Financials for Regeneron Pharmaceuticals Inc.

Latest News

dow

nasdaq

s&p 500

Kiosk